Answers are grounded in this paper and cite their sources.
Ophthalmic bilastine effectively reduced ocular itching for 16 hours after administration, suggesting that it could be used as a once-daily treatment for the signs and symptoms of allergic conjunctivitis. ClinicalTrials.gov identifier: NCT03479307.
No takes yet. Share an insight, caveat, or question.
Gomes et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: